Bausch + Lomb Corp. Newsroom

Bausch + Lomb to Announce 2024 Financial Results

TipRanksJan 22 09:09 ET

Press Release: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19

Dow JonesJan 22 07:03 ET

Barclays Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Maintains Target Price $19

Moomoo NewsJan 22 03:32 ET · Ratings

Barclays Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Raises Target Price to $19

Moomoo NewsJan 21 07:34 ET · Ratings

Bausch & Lomb Analyst Ratings

BenzingaJan 16 09:42 ET · Ratings

Wells Fargo Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Announces Target Price $24

Moomoo NewsJan 16 06:31 ET · Ratings

Express News | Live On CNBC, Bausch + Lomb CEO Discusses Sale Rumors, Shares See Volume To The Upsde

BenzingaJan 14 11:52 ET

Aehr Test Systems Posts Weak Results, Joins Trump Media & Technology Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

BenzingaJan 14 08:01 ET

Bausch & Lomb (BLCO.US) advanced enVista Aspire intraocular lens was launched in the European Union.

Bausch + Lomb (BLCO.US) announced on Monday that after obtaining CE certification at the end of last year, the enVista Aspire monofocal and aspheric intraocular lenses (IOLs) have been launched in the European Union.

Zhitong FinanceJan 13 08:10 ET

Press Release: Bausch + Lomb Bolsters Pipeline With Acquisition of Whitecap Biosciences

Dow JonesJan 13 07:00 ET

Bausch + Lomb Launches EnVista Aspire Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union

BusinesswireJan 13 06:00 ET

Is Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20?

Yahoo FinanceJan 12 09:30 ET

Wells Fargo Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating

Moomoo NewsJan 11 10:32 ET · Ratings

InflammX Therapeutics Entered Option Agreement With Bausch + Lomb Granting Right To Be Acquired By BLCO

BenzingaJan 10 08:38 ET

Character Biosciences Announces Collaboration With Bausch + Lomb to Transform Ophthalmology With Precision Medicine

BusinesswireJan 10 08:00 ET

City Therapeutics Announces Strategic Collaboration With Bausch + Lomb to Develop a Novel RNAi-Based Treatment for Geographic Atrophy

BusinesswireJan 10 06:00 ET

Outcome Capital Congratulates Elios Vision on the Acquisition by Bausch + Lomb

BusinesswireJan 9 09:00 ET

Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual "Faces of Glaucoma" Campaign and Fundraising Challenge

BusinesswireJan 7 07:00 ET

Evercore Upgrades Bausch + Lomb Corp.(BLCO.US) to Buy Rating, Raises Target Price to $22

Moomoo NewsJan 2 07:32 ET · Ratings

Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

BusinesswireJan 2 07:00 ET